Home Applications 217899 Application 217899
Type NDA
Sponsor GILEAD SCIENCES INC Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 LIVDELZI SELADELPAR LYSINE CAPSULE;ORAL EQ 10MG BASE Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N217899-001 LIVDELZI SELADELPAR LYSINE EQ 10MG BASE CAPSULE / ORAL RLD, RS 2024-08-14
Orange Book patents# Current patent rows page 1 of 1 · 6 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N217899-001 7301050 2026-08-02 Drug substance, Drug product 2024-08-30 N217899-001 7709682 2026-09-13 Drug substance 2024-08-30 N217899-001 10272058 2035-03-19 U-1854 2024-08-30 N217899-001 11406611 2035-03-19 U-1854 2024-08-30 N217899-001 11596614 2035-03-19 U-1854 2024-08-30 N217899-001 9486428 2035-03-19 U-1854 2024-08-30
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 2 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N217899-001 NCE 2029-08-14 N217899-001 ODE-486 2031-08-14
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N217899-001 LIVDELZI EQ 10MG BASE CAPSULE / ORAL RLD, RS 2024-08-14 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217899-001 LIVDELZI EQ 10MG BASE CAPSULE / ORAL RLD, RS 2024-08-14 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N217899-001 LIVDELZI EQ 10MG BASE CAPSULE / ORAL RLD, RS 2024-08-14 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217899-001 LIVDELZI EQ 10MG BASE CAPSULE / ORAL RLD, RS 2024-08-14 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217899-001 LIVDELZI EQ 10MG BASE CAPSULE / ORAL RLD, RS 2024-08-14 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N217899-001 LIVDELZI EQ 10MG BASE CAPSULE / ORAL RLD, RS 2024-08-14 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N217899-001 LIVDELZI EQ 10MG BASE CAPSULE / ORAL RLD, RS 2024-08-14 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N217899-001 LIVDELZI EQ 10MG BASE CAPSULE / ORAL RLD, RS 2024-08-14 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N217899-001 LIVDELZI EQ 10MG BASE CAPSULE / ORAL RLD, RS 2024-08-14 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N217899-001 LIVDELZI EQ 10MG BASE CAPSULE / ORAL RLD, RS 2024-08-14 d06236e962d9…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217899-001 LIVDELZI EQ 10MG BASE CAPSULE / ORAL RLD, RS 2024-08-14 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 2 · 66 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N217899-001 7301050 2026-08-02 Drug substance, Drug product 2024-08-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217899-001 7709682 2026-09-13 Drug substance 2024-08-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217899-001 10272058 2035-03-19 U-1854 2024-08-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217899-001 11406611 2035-03-19 U-1854 2024-08-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217899-001 11596614 2035-03-19 U-1854 2024-08-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217899-001 9486428 2035-03-19 U-1854 2024-08-30 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217899-001 7301050 2026-08-02 Drug substance, Drug product 2024-08-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217899-001 7709682 2026-09-13 Drug substance 2024-08-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217899-001 10272058 2035-03-19 U-1854 2024-08-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217899-001 11406611 2035-03-19 U-1854 2024-08-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217899-001 11596614 2035-03-19 U-1854 2024-08-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217899-001 9486428 2035-03-19 U-1854 2024-08-30 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N217899-001 7301050 2025-08-02 Drug substance, Drug product 2024-08-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217899-001 7709682 2026-09-13 Drug substance 2024-08-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217899-001 10272058 2035-03-19 U-1854 2024-08-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217899-001 11406611 2035-03-19 U-1854 2024-08-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217899-001 11596614 2035-03-19 U-1854 2024-08-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217899-001 9486428 2035-03-19 U-1854 2024-08-30 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217899-001 7301050 2025-08-02 Drug substance, Drug product 2024-08-30 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217899-001 7709682 2026-09-13 Drug substance 2024-08-30 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217899-001 10272058 2035-03-19 U-1854 2024-08-30 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217899-001 11406611 2035-03-19 U-1854 2024-08-30 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217899-001 11596614 2035-03-19 U-1854 2024-08-30 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217899-001 9486428 2035-03-19 U-1854 2024-08-30 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217899-001 7301050 2025-08-02 Drug substance, Drug product 2024-08-30 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217899-001 7709682 2026-09-13 Drug substance 2024-08-30 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217899-001 10272058 2035-03-19 U-1854 2024-08-30 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217899-001 11406611 2035-03-19 U-1854 2024-08-30 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217899-001 11596614 2035-03-19 U-1854 2024-08-30 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217899-001 9486428 2035-03-19 U-1854 2024-08-30 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N217899-001 7301050 2025-08-02 Drug substance, Drug product 2024-08-30 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N217899-001 7709682 2026-09-13 Drug substance 2024-08-30 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N217899-001 10272058 2035-03-19 U-1854 2024-08-30 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N217899-001 11406611 2035-03-19 U-1854 2024-08-30 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N217899-001 11596614 2035-03-19 U-1854 2024-08-30 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N217899-001 9486428 2035-03-19 U-1854 2024-08-30 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N217899-001 7301050 2025-08-02 Drug substance, Drug product 2024-08-30 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N217899-001 7709682 2026-09-13 Drug substance 2024-08-30 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N217899-001 10272058 2035-03-19 U-1854 2024-08-30 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N217899-001 11406611 2035-03-19 U-1854 2024-08-30 2680178bc6a6…
Observed Orange Book exclusivity history# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Livdelzi SELADELPAR LYSINE Gilead Sciences, Inc 89f79d98-135c-40b2-a585-6996c04e599c 2026-02-03 Warnings, Adverse reactions Exact identifier application applno (NDA): 217899 application number: NDA217899
Documents# Document, Submission type, Date table Document Submission type Date 84948 SUPPL 2026-02-05 84898 SUPPL 2026-02-03 79629 ORIG 2024-09-16 79413 ORIG 2024-08-16 79400 ORIG 2024-08-14